The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Quantbot Technologies LP

Quantbot Technologies LP decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 80.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,299 shares of the medical device company's stock after selling 42,048 shares during the quarter. Quantbot Technologies LP's holdings in Cooper Companies were worth $947,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Byrne Asset Management LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies during the fourth quarter worth approximately $34,000. Brown Brothers Harriman & Co. boosted its stake in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after buying an additional 275 shares during the last quarter. West Financial Advisors LLC purchased a new stake in Cooper Companies in the 4th quarter valued at $49,000. Finally, Atala Financial Inc purchased a new position in shares of Cooper Companies during the 4th quarter worth $51,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Stifel Nicolaus reduced their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Piper Sandler restated an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Remove Ads

Cooper Companies Stock Down 1.4 %

Cooper Companies stock traded down $1.21 during mid-day trading on Friday, reaching $83.77. 1,736,366 shares of the company's stock were exchanged, compared to its average volume of 1,343,868. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The company has a market cap of $16.75 billion, a P/E ratio of 42.96, a P/E/G ratio of 2.25 and a beta of 1.02. The company has a fifty day moving average of $89.33 and a 200-day moving average of $97.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.